Latest News & Features
Americas
Amgen’s subsidiary Immunex has called on the US Court of Appeals for the Federal Circuit to reject Sandoz’s request for an en banc rehearing of a dispute over biologic Enbrel. 27 August 2020
Generics
Teva Pharmaceuticals has been charged with conspiring to fix prices, rig bids, and allocate customers for generic drugs, the US Department of Justice has announced. 26 August 2020
Americas
Intercept Pharmaceuticals is suing Canadian generics manufacturer Apotex over a proposed version of autoimmune drug Ocaliva. 26 August 2020
Asia-Pacific
Law firm Spruson & Ferguson has appointed four new principals across the firm as part of its 2020 promotions. The appointments have been made in the firm’s Hong Kong, Singapore, Sydney and Melbourne offices. 25 August 2020
Americas
Swiss-based Ferring Pharmaceuticals has prevailed in a patent dispute with rivals Serenity Pharmaceuticals and Reprise Biopharmaceuticals over a nighttime urination, or nocturia, treatment. 25 August 2020
Big Pharma
In a boost for generic pharma companies, a U-turn by the EU’s highest court removed protection for repurposed active substances, as Robert Stephen and Gareth Morgan of CMS Cameron McKenna Nabarro Olswang explain. 25 August 2020
Americas
A district judge has given India-based Dr Reddy’s the greenlight to move forward with its antitrust counterclaims against Indivior. 25 August 2020
Biotechnology
In an LSPN Connect session, Millipore’s senior corporate patent counsel, Ben Sodey, and head of legal and IP at Arbor, Kelly Morgan, shared their insights on the latest developments in this area of gene editing technology. 21 August 2020
Big Pharma
The FTC should avoid reviewing communications between Martin Shkreli and his attorneys, but these are not protected under the Privacy Act, a New York federal judge has ruled. 21 August 2020
article
A lot of strides have been made in the field of CRISPR systems, and MilliporeSigma and Arbor Biotechnologies are at the heart of developments. In this unmissable live panel, Millipore’s Senior Corporate Patent Counsel, Ben Sodey, and Kelly Morgan, Head of Legal & IP at Arbor, will share their insights on the latest developments in this arena, and answering a host of questions, including. 20 August 2020